Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Current Advances in Hepatocellular Carcinoma: Transition from: Traditional to Advanced Technology
Current Cancer Drug Targets
2025
Gautam S.
Angiogenesis Is Associated With Aggressive Biology That Counterbalances With Tumor Immunogenicity in Hepatocellular Carcinoma
World Journal of Oncology
2025
Vaghjiani R.
Open Access
Clinical effect analysis of different regimens of capecitabine in the treatment of patients with advanced colon cancer
Journal of Chemotherapy
2025
Ju F.
Efficacy and Safety of Metronomic Capecitabine in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
Journal of Gastrointestinal Cancer
December 2024
Gupta N.
All Open Access
BCL11B expression in hepatocellular carcinoma relates to chemosensitivity and clinical prognosis
Cancer Medicine
July 2023
Abe H.
Open Access
Analysis of the Prognosis Prediction Ability of a Necroptosis-Related Gene Signature and its Relationship With the Hepatocellular Carcinoma Immune Microenvironment Using Bioinformatics Analysis and Experimental Validation
Technology in Cancer Research and Treatment
January-December 2023
Guan R.
Open Access
A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma
Frontiers in Immunology
8 July 2022
Li G.
Open Access
RMI2 is a prognostic biomarker and promotes tumor growth in hepatocellular carcinoma
Clinical and Experimental Medicine
May 2022
Li Y.
An Overview of the Synthetic Route to the Marketed Formulations of Pyrimidine: A Review
Mini Reviews in Medicinal Chemistry
April 2022
Kumar A.
Case Report: Durable Response to Very Low Dose Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma
Frontiers in Oncology
16 December 2021
Tang T.Y.
Open Access
Capecitabine Treatment: A Safe and Effective Therapy in the Field of Oncology
Clinical Colorectal Cancer
September 2021
Beenet L.
CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma
Frontiers in Oncology
16 August 2021
Li B.
Open Access
Systemic therapies in elderly patients with advanced hepatocellular carcinoma: Do not forget metronomic capecitabine
European Journal of Surgical Oncology
August 2021
Wilhelmi M.
Systemic therapies in elderly patients with advanced hepatocellular carcinoma: do not forget metronomic capecitabine
European Journal of Surgical Oncology
August 2021
Kapacee Z.A.
Ramucirumab and other new systemic therapies for hepatocellular carcinoma: Still uncovered the problem of Child-Pugh B patients
Chinese Clinical Oncology
April 2021
Wilhelmi M.
Open Access
Novel ferrocene derivatives induce G0/G1 cell cycle arrest and apoptosis through the mitochondrial pathway in human hepatocellular carcinoma
International Journal of Molecular Sciences
2 March 2021
Zheng J.
Open Access
Gene Polymorphism of MUC15, MMP14, BRAF, and COL1A1 Is Associated with Capsule Formation in Hepatocellular Carcinoma
Canadian Journal of Gastroenterology and Hepatology
2021
Sun W.
Open Access
Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma
Science Progress
2021
Wang J.
Open Access
The Effect of Ferroptosis-Related Genes on Prognosis and Tumor Mutational Burden in Hepatocellular Carcinoma
Journal of Oncology
2021
Zhang H.
Open Access
A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma
Canadian Journal of Gastroenterology and Hepatology
2021
Diesinger T.
Open Access
Upregulation of Nei-Like DNA Glycosylase 3 Predicts Poor Prognosis in Hepatocellular Carcinoma
Journal of Oncology
2021
Wu D.
Open Access
Curative effect of endostar combined with oxaliplatin in the treatment of primary hepatic carcinoma and its influence on immune cells
Oncology Letters
April 2019
Lei C.
Open Access
Immunotherapy in hepatocellular carcinoma
Annals of Hepatology
March - April 2019
Buonaguro L.
Open Access
Potentiating cancer vaccine efficacy in liver cancer
Oncoimmunology
3 October 2018
Tagliamonte M.
Open Access
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation
Journal of Cancer Research and Clinical Oncology
1 February 2018
Trevisani F.
All Open Access, Green